Workflow
万东医疗(600055) - 2014 Q3 - 季度财报
WDMWDM(SH:600055)2014-10-24 16:00

Financial Performance - Operating revenue decreased by 9.52% to CNY 443,270,932.06 for the first nine months compared to the same period last year[6] - Net profit attributable to shareholders decreased by 24.51% to CNY 13,976,053.18 for the first nine months compared to the same period last year[6] - Basic earnings per share decreased by 24.42% to CNY 0.065 compared to the same period last year[6] - Operating revenue for Q3 was ¥138,449,960.28, down 9.0% from ¥152,203,875.88 in the same period last year[31] - Net profit for the period was ¥2,867,561.51, an increase of 96.1% compared to ¥1,464,127.51 in Q3 of the previous year[31] - The company's operating revenue for Q3 2023 was ¥117,125,115.06, a decrease of 12.5% compared to ¥133,809,124.51 in Q3 2022[34] - Year-to-date revenue (January to September 2023) reached ¥394,713,463.23, down 5.4% from ¥417,465,355.93 in the same period last year[34] - The net profit for Q3 2023 was ¥17,478,871.13, a decline of 3.5% from ¥18,113,059.75 in Q3 2022[34] - The total profit for the first nine months of 2023 was ¥41,733,706.16, down 11.7% from ¥47,223,330.49 in the previous year[34] Assets and Liabilities - Total assets increased by 2.13% to CNY 1,167,349,445.34 compared to the end of the previous year[6] - The company's total assets as of September 30, 2014, amounted to CNY 1,167,349,445.34, an increase from CNY 1,143,049,704.73 at the beginning of the year[25] - Current assets decreased from CNY 765,966,937.40 to CNY 717,788,544.49, primarily due to a reduction in cash and cash equivalents from CNY 189,078,647.83 to CNY 124,560,412.44[25] - The company's total liabilities increased from CNY 497,516,990.87 to CNY 517,990,051.05, with short-term borrowings rising from CNY 120,000,000 to CNY 170,000,000[26] - The total non-current assets increased from CNY 377,082,767.33 to CNY 449,560,900.85, driven by growth in long-term receivables and fixed assets[26] - Total assets increased to ¥1,109,964,443.15 from ¥1,079,352,131.16, reflecting a growth of approximately 2.1%[29] - Current assets decreased to ¥626,592,422.33 from ¥662,045,248.65, a decline of about 5.4%[28] - Total liabilities remained stable at ¥471,028,709.54, slightly down from ¥471,327,603.71[29] Cash Flow - Cash flow from operating activities improved, with a net cash flow of CNY -60,013,152.96, an improvement from CNY -90,763,550.96 in the previous year[6] - The cash flow from operating activities for the first nine months of 2023 was negative at -¥60,013,152.96, an improvement from -¥90,763,550.96 in the same period last year[35] - The net cash flow from financing activities for the first nine months of 2023 was positive at ¥42,058,537.80, a turnaround from -¥64,871,669.99 in the same period last year[37] - The net cash flow from operating activities was -¥42,079,047.93, an improvement compared to -¥105,841,981.47 in the same period last year[39] - The company reported a total cash outflow from operating activities of ¥470,569,229.44, a decrease from ¥526,458,494.67 in the previous year[39] Shareholder Information - The total number of shareholders reached 14,324, indicating a stable shareholder base[9] - The company’s major shareholder, Beijing Medical Group, transferred 51.51% of its shares (111,501,000 shares) to Jiangsu Yuyue Technology Development Co., Ltd., pending regulatory approvals[13] Inventory and Receivables - The company’s inventory increased from CNY 212,347,037.48 to CNY 229,268,934.36, indicating a potential buildup in stock[25] - The company’s accounts receivable decreased slightly from CNY 215,064,066.73 to CNY 211,295,225.56, reflecting stable collection practices[25] Accounting Changes - The company has implemented new accounting standards effective July 1, 2014, which have adjusted various financial statement items without impacting total assets, liabilities, or net profit significantly[17] - The company reported a net profit impact of approximately CNY 1,680,500 due to new accounting standards affecting employee benefits[21] - The company adjusted employee compensation liabilities, resulting in an increase of approximately CNY 28,508,600 in liabilities and a corresponding decrease in equity[19]